APA

Dabbous H. M., Montasser I. F., Sakr M. A., Refai R., Sayam M., Abdelmonem A., Sayed H., F Abdelghafar M., Bahaa M. & S Elmeteini M. (20160622). Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?. : Hepatitis monthly.

Chicago

Dabbous Hany M, Montasser Iman F, Sakr Mohamed A, Refai Rasha, Sayam Moataz, Abdelmonem Ahmed, Sayed Hany, F Abdelghafar Mohamed, Bahaa Mohamed and S Elmeteini Mahmoud. 20160622. Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?. : Hepatitis monthly.

Harvard

Dabbous H. M., Montasser I. F., Sakr M. A., Refai R., Sayam M., Abdelmonem A., Sayed H., F Abdelghafar M., Bahaa M. and S Elmeteini M. (20160622). Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?. : Hepatitis monthly.

MLA

Dabbous Hany M, Montasser Iman F, Sakr Mohamed A, Refai Rasha, Sayam Moataz, Abdelmonem Ahmed, Sayed Hany, F Abdelghafar Mohamed, Bahaa Mohamed and S Elmeteini Mahmoud. Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?. : Hepatitis monthly. 20160622.